Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

NCT04713761 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Toripalimab

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China